CA2139896C - Utilisation d'un agent antinauseeux chez des patients en phase terminale - Google Patents
Utilisation d'un agent antinauseeux chez des patients en phase terminale Download PDFInfo
- Publication number
- CA2139896C CA2139896C CA002139896A CA2139896A CA2139896C CA 2139896 C CA2139896 C CA 2139896C CA 002139896 A CA002139896 A CA 002139896A CA 2139896 A CA2139896 A CA 2139896A CA 2139896 C CA2139896 C CA 2139896C
- Authority
- CA
- Canada
- Prior art keywords
- nausea
- vomiting
- terminally ill
- symptoms
- humans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002139896A CA2139896C (fr) | 1995-01-10 | 1995-01-10 | Utilisation d'un agent antinauseeux chez des patients en phase terminale |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002139896A CA2139896C (fr) | 1995-01-10 | 1995-01-10 | Utilisation d'un agent antinauseeux chez des patients en phase terminale |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2139896A1 CA2139896A1 (fr) | 1996-07-11 |
| CA2139896C true CA2139896C (fr) | 2000-03-28 |
Family
ID=4155014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002139896A Expired - Lifetime CA2139896C (fr) | 1995-01-10 | 1995-01-10 | Utilisation d'un agent antinauseeux chez des patients en phase terminale |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2139896C (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2350195C (fr) * | 2000-12-20 | 2003-06-10 | Duchesnay Inc. | Preparation a delai d'action rapide de chlorhydrate de pyridoxine et de doxylamine succinate |
| ES2229876B1 (es) * | 2001-06-26 | 2006-03-01 | Duchesnay Inc. | Formulacion de accion rapida. |
-
1995
- 1995-01-10 CA CA002139896A patent/CA2139896C/fr not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2139896A1 (fr) | 1996-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU774847B2 (en) | Use of dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants | |
| US8309535B2 (en) | Compositions and methods to treat recurrent medical conditions | |
| US5589480A (en) | Topical application of opioid analgesic drugs such as morphine | |
| Baltodano et al. | Verapamil vs quinine in recumbent nocturnal leg cramps in the elderly | |
| CA3213864A1 (fr) | Regime posologique de tradipitant | |
| BR112019015832A2 (pt) | Método de tratamento de zumbido, método de tratamento de perda auditiva neurossensorial aguda, e método de tratamento da doença de ménière | |
| Cheng et al. | Dihydroergotoxine mesylate for the treatment of sialorrhea in Parkinson's disease | |
| Lipman | Drug therapy in cancer pain | |
| US20150352040A1 (en) | Topical peripheral neuro-affective (tpna) therapy | |
| Lewis et al. | Overdose of tricyclic anti-depressants and deductions concerning their cerebral action | |
| CA2139896C (fr) | Utilisation d'un agent antinauseeux chez des patients en phase terminale | |
| Napoliello et al. | Buspirone: a worldwide update | |
| CN101653605A (zh) | 戒毒治疗、戒毒治疗套组以及药剂摄取 | |
| Olsen et al. | Oral glycopyrrolate alleviates drooling in a patient with tongue cancer | |
| Lemere | Drug habituation | |
| Lader | Antianxiety drugs: clinical pharmacology and therapeutic use | |
| US20140148465A1 (en) | Compositions and Methods to Improve Treatment of Medical Conditions Using D-Cycloserine | |
| US20070142367A1 (en) | Method and medicine for treating gastrointestinal disorder including fecal incontinence | |
| WO2009147831A1 (fr) | Procédé et composition pharmaceutique pour le traitement de troubles mentaux | |
| De Conno | Cancer pain relief: A practical manual | |
| Magat et al. | Oral spasmolytics | |
| FLAHERTY | Symptom management: nausea and vomiting | |
| Macleod et al. | Other symptoms and the psyche | |
| Tennant | Overcoming Opiophobia & Doing Opioids Right | |
| Libretto | Use of transdermal fentanyl in patients with continuous non-malignant pain: a case report series |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20150112 |